- Home
- FATE vs USAU Comparison
FATE vs USAU Comparison
Compare FATE & USAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FATE | USAU |
|---|---|---|
| Founded | 2007 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.0M | 242.1M |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | FATE | USAU |
|---|---|---|
| Price | $1.29 | $10.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $5.72 | ★ $26.50 |
| AVG Volume (30 Days) | ★ 1.5M | 165.6K |
| Earning Date | 11-05-2026 | 12-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.88 | ★ 36.11 |
| EPS | N/A | ★ N/A |
| Revenue | $6,646,000.00 | ★ $17,402,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.72 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.95 | $9.96 |
| 52 Week High | $3.23 | $23.72 |
Technical Indicators
Market Signals| Indicator | FATE | USAU |
|---|---|---|
| Relative Strength Index (RSI) | 23.18 | 39.52 |
| Support Level | $1.07 | $10.20 |
| Resistance Level | $1.38 | $16.65 |
| Average True Range (ATR) | 0.16 | 0.64 |
| MACD | -0.07 | 0.13 |
| Stochastic Oscillator | 7.35 | 27.73 |
Price Performance
Historical ComparisonAbout FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About USAU U.S. Gold Corp.
U.S. Gold Corp is a gold, copper and precious metals development and exploration company pursuing exploration opportunities mainly in Wyoming, Nevada and Idaho. It is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada and the Challis Gold Project in Idaho. The company is engaged in the exploration and evaluation of its mineral properties, which is the single operating segment.